Nonionic Low-Osmolar Contrast Media Have No Impact on Major Adverse Cardiac Events in Patients Undergoing Coronary Stenting with Appropriate Antiplatelet Therapy

Catheterization and Cardiovascular Interventions

Volumn 60, Issue 4, 2003, Pages 477-482

  Danzi, Gian B ^a,b   Capuano, Cinzia ^a   Sesana, Marco ^a   Predolini, Simonetta ^a   Baglini, Roberto ^a  

^a Poliambulanza Hospital   (Italy)

^b Catheterization Laboratory   (Italy)

Author keywords

Contrast agents; Percutaneous coronary interventions; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CONTRAST MEDIUM; IOPAMIDOL; IOPROMIDE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; TICLOPIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IOHEXOL; IOPAMIDOL; IOXAGLIC ACID; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PLATELET AGGREGATION INHIBITORS; STENTS;

EID: 0344844459     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10670     Document Type: Article

References (25)

1. Schräder R, Esch I, Ensslen R, Fach WA, Merle H, Schere D, Sievert H, Friedrich H, Zeplin HE. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol 1999;33:395-402.
2. Bertrand ME, Esplugas E, Piessens J, Rasch W. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Circulation 2000;101:131-136.
3. Davidson CJ, Laskey WK, Hermiller JB, Harrison K, Matthai W, Vliestra RE, Brinker JA, Kereiakes DJ, Muhlestein JB, Lansky A, Poppma JJ, Buchbinder M, Hirshfeld JW. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 2000;101:2172-2177.
4. Idee JM, Corot C. Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology: pathophysiology and clinical aspects. Fundam Clin Pharmacol 1999;13:613-623.
5. Scheller B, Hennen B, Pohl A, Schieffer H, Markwirt T. Acute and subacute stent occlusion: risk-reduction by ionic contrast media. Eur Heart J 2001;22:385-391.
6. Danzi GB, Capuano C, Fiocca L, Dallavalle F, Pirelli S, Mauri L, Quaini E. Stent implantation without predilation in patients with a single, noncalcified coronary artery lesion. Am J Cardiol 1999;84:1250-1253.
7. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD, Kent KM, Lansky AJ, Stone GW, Leon MB. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 2001;38:638-641.
8. Tommasini G, Rubartelli P, Piaggio M. A deterministic approach to automated stenosis quantification. Catheter Cardiovasc Interv 1999;48:435-445.
9. Danzi GB, Pirelli S, Mauri L, Testa R, Ciliberto GR, Massa D, Lotto AA, Campolo L, Parodi O. Which variable of stenosis severity best describes the significance of an isolated left anterior descending coronary artery lesion? correlation between quantitative coronary angiography, intracoronary Doppler measurements and high dose dipyridamole echocardiography. J Am Coll Cardiol 1998;31:526-533.
10. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. Circulation 1988;78:486-502.
11. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
12. Grabowski EF. A hematologist's view of contrast media, clotting in angiography syringes and thrombosis during coronary angiography. Am J Cardiol 1990;26:23F-25F.
13. Fareed J, Walenga JM, Saravia GE, Moncada RM. Thrombogenic potental of nonionic contrast media. Radiology 1990;174:321-325.
14. Stormorken H, Skalpe IO, Testar MC. Effect of various contrast media on coagulation, fibrinolysis and platelet function: an in vitro and in vivo study. Invest Radiol 1986;21:348-354.
15. Riemann CD, Massey CV, McCarron DL, Borkowski P, Johnson PC, Ziskind AA. Ionic contrast agent-mediated-endothelial injury causes increased deposition to vascular surfaces. Am Heart J 1993;125:71-78.
16. Owens MR, Ribes JA, Marder VJ, Francis CW. Effects of ionic and nonionic radiographic contrast agents on endothelial cells in vitro. J Lab Clin Med 1992;119:315-319.
17. Cucherat M, Leizorovicz A. Effects of nonionic versus ionic contrast media on abrupt vessel closure and ischemic complications after angioplasty: a meta-analysis. Am J Cardiol 1999;84(Suppl 6):98P.
18. Legrand V. Ionic or nonionic contrast media during coronary intervention: does it make a difference? Eur Heart J 2001;22:353-354.
19. Schuhlen H, Kastrati A, Pache J, Dirschinger J, Schomig A. Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen. J Am Coll Cardiol 2001;37:2066-2073.
20. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation 1989;80:198-205.
21. Aguirre FV, Simoons ML, Ferguson JJ, Fizpatric SE, Anderson KM, Kern MJ, Tcheng JE. Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: meta-analysis of clinical trials with abciximab. Circulation 1997;96(Suppl 1):161.
22. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Schomig A. Diabetes mellitus and the clinical outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866-1873.
23. Bhatt DL, Marso SP, Lincoff M, Wolski KE, Ellis SG, Topol EJ. Abciximab reduced mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000;35:922-928.
24. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 1996;27:494-503.
25. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Chauhan MS, Rodriguez O, Kuntz RE. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-1971.